Skip to content

DUOPHARM

Active
Public limited companyfounded 197748 years activeDendermondsesteenweg 7, 9280 Lebbeke, BelgiumKBO/BCE: BE 0417.916.679
Summary

For DUOPHARM, one filing cycle of the annual accounts is missing. The 2024 annual accounts show equity of €1.0m and a net result of €231,411. Equity remains stable across the filed fiscal years (±0.4% per year). Its solvency ranks better than 83% of 9,656 sector peers (NACE 47, fiscal year 2024). The company has been active since 1977 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
#5 oldest company in Lebbeke, Wholesale and retail trade sector1 site
Size
€1.4mtotal assets 2024
Staff
1.2 FTE
Equity
€1.0m
Profit
€231,411
Turnover not published (abridged schema)
Financial health
Bankruptcy probabilitywithin 12 months
1.2%
2024 figures too old to score
Structure
Accounts 250 days overdue0 of 6 deeds read
Signals- Figures for FY 2024 (filed 06-01-2025)- 1 change of registered office in 24 months- Annual accounts not filed+ Founded in 1977+ Liquidity: current ratio 3.95, cash €416,061Latest accounts filed on timeShow the evidence

Checked score

No current score
Figures too old
The available figures for FY 2024 are too old to assess current financial health.
Filing: One filing cycle is missing
Financial strength, FY 2024 · tick = 2023
Strong
Solvency 96-4
equity 71.3% of total assets
Liquidity 81+9
short-term debt 18.4% · cash 29.1%
Profitability 89-2
return on assets 16.2%
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,169 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.2%▲ +0.1 percentage points vs 01-2026 03-2026: 0.3%▲ +0.1 percentage points vs 02-2026 04-2026: 0.5%▲ +0.2 percentage points vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.7%▲ +0.2 percentage points vs 05-2026 07-2026: 1.3%▲ +0.6 percentage points vs 06-2026 08-2026: 1.3%● unchanged vs 07-2026 09-2026: 1.3%● unchanged vs 08-2026highest value 10-2026: 1.2%▼ -0.1 percentage points vs 09-2026
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Figures for FY 2024 (filed 06-01-2025)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian State Gazette
lowers risk · Founded in 1977
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
lowers risk · Liquidity: current ratio 3.95, cash €416,061
NBB · annual accounts
raises risk · Annual accounts not filed
The financial year that closed on 30-06-2025 was due at the National Bank by 31-01-2026. Nothing is on record, 250 days later.
NBB · 10 filings
Position against the passed deadline
30-06-2025 close31-01-2026 deadline08-10-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2024 was due by 31-01-2025 and was filed on 02-01-2025, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
29 days early
2023
2 days early
2022
39 days early
2021
on the day
2020
4 days early
2019
8 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 14 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · abbreviated…
  2. Annual accounts filedfiscal year 2023 · abbreviated…
  3. Highest result since 2019net €288,617 ▲19.1%

Key points

  • Risk: Accounts not fileddeadline was 31-01-2026 250 days late View
  • Positive: Among the best 13% on net resultsector median €44,138 · 9,656 companies €231,411 View
  • Positive: 6 profitable years in a rowprofit 2024: €231,411 6 years View
  • Active since 1977founded 15-12-1977 48 years View

By topic

Financials

Fiscal year
2024
Total assets
€1.4m
Profit
€231,411
Solvency
71.3%
Total assets▼ 12.7%
Net result
20192024
Go to Financials

Timeline

Events
14
Since
2016
  1. 30-06-2023Liquidity doubles
  2. 30-06-2023Equity above €1m
  3. 23-12-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
15-12-1977
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.